One person, one family, one community at a time, the Hunter Medical Research Institute (HMRI) fights the illnesses affecting lives throughout the world. Our translational research model aligns over 1500 researchers, students and support staff from Hunter New England Health and the University of Newcastle, inspiring new discoveries to deliver a healthier future.

Throughout Newcastle and the Hunter region researchers, students and support staff are working across seven HMRI Research Programs to prevent, cure and treat a diverse range of serious illnesses by translating research findings made in the laboratory into real health treatments and preventative strategies. Internationally-recognised research outcomes are being achieved in asthma and airway diseases, cancer, diabetes, mental health, nutrition, pregnancy and reproduction, stroke and more. Collaborations are being conducted with institutes on all points of the globe.

HMRI provides vital funding and facilities to fuel research, but the heart and soul of the Institute are people – the researchers, the generous donors and supporters, the committed volunteers, and the patients who participate in trials and ultimately benefit from the research results.

Upcoming Events

Sports Concussion Clinic Lunch
Sports Concussion Clinic Lunch
October 27, 2017 - 12:30pm to 4:00pm

Come along to the inaugural Sports Concussion Clinic Lunch hosted by Marc Glanville raising funds for concussion research.

March 16, 2018 - 2:00pm to 2:15pm

ASX Thomson Reuters Charity Foundation are once again running a charity auction where HMRI can benefit from the ticket sales!

Latest News & Articles

Oct 20 2017

Researchers will explore Virtual Reality training to build psychological resilience among Australian troops ahead of deployment.

Oct 20 2017

/research/viruses-infections-immunity-vaccines-asthmaRespiratory leader Professor Peter Gibson has been elected as a Fellow of the Australian Academy of Health and Medical Sciences.

Oct 12 2017

Researchers have secured more than $6 million in national funding, including $2.5 million for a world-first research centre to test a range of cannabinoids.

Sep 25 2017

HMRI researcher Dr Matt Dun has revealed a more targeted way of treating T-cell acute lymphoblastic leukaemia (T-ALL), an aggressive cancer prevalent in children.